Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will examine the efficacy of a clinical intervention for improving emotional processing in individuals with MS and TBI.(1)The main outcome measure will be changes in emotional processing measures from pre to post treatment.
(2)This study will also assess the impact of the emotional processing intervention on changes in pre and post treatment depression and anxiety, as well as fatigue.(3) This study will additionally measure the impact of the emotional processing intervention on cognitive functioning, specifically processing speed, attention and executive abilities. This will be accomplished through the completion of a neuropsychological battery prior to and following the completion of treatment.(4)Finally, the investigators will measure the impact of the intervention on quality of life and social functioning, utilizing a pre and post treatment assessment consisting of measures of self-efficacy, quality of life, functional abilities, and awareness.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Computerized Tests | Experimental |
| |
| Placebo Control | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Emotional Processing Training | Behavioral |
| ||
| Placebo Control |
| Measure | Description | Time Frame |
|---|---|---|
| Change in scores on Facial Expression Identification Task (FEIT) | The FEIT assesses one's ability to correctly identify and discriminate emotions from faces | Scores will be assessed at two time-points, baseline (week 1) and post-intervention (week 8) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in scores on Emotion Regulation Questionnaire (ERQ) | The ERQ is a self-report measure of the use of 2 emotional regulation strategies: cognitive reappraisal and expressive suppression | Scores will be assessed at two time-points, baseline (week 1) and post-intervention (week 8) |
| Change in scores on Satisfaction with Life Scale (SWLS) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kessler Foundation | East Hanover | New Jersey | 07936 | United States |
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| D000070642 | Brain Injuries, Traumatic |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Behavioral |
|
The SWLS is a self-report measure of quality of life |
| Scores will be assessed at two time-points, baseline (week 1) and post-intervention (week 8) |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D001930 | Brain Injuries |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D006259 | Craniocerebral Trauma |
| D020196 | Trauma, Nervous System |
| D014947 | Wounds and Injuries |